![](https://investorshub.advfn.com/uicon/677007.png?cb=1537174437)
Sunday, November 18, 2018 1:40:18 PM
That's a serious answer too.
Accounts receivable on Dec 31, 2017: $4,801. Accounts receivable on Sept 30, 2018: $14,000.
292% increase in accounts receivable? From what? Well, apparently they have succeeded in commercializing their patented CaverStem procedure and they even told us that they held back on revenue for Q3 to make sure everything was positioned the best for patients, docs and CMTH. Q4 will show that throttled back revenue and this is just the beginning.
Clinics are going to be, and many ALREADY ARE, cranking out treatments WORLDWIDE and when they're in full swing, revenue is going to bust loose.
Don't worry with the OS, revenues will cure what ails and market cap will absolutely reset to make this PPS trash a thing of the past.
If $CELZ has a market cap of $500M and 2B in OS, it's worth 25 cents. If it's $500M market cap and 1B OS, then its 50 cents. If it gets fairly valued for CaverStem, FemCelz, StemSpine and AminoStem...not to mention the other patents pending...then what Market Cap would it have? $1B? $10B? $20B? If it takes another Billion in OS to get this thing zooming with insane revenue, so be it. At $20B market cap and 2 Billion OS, the stock is worth $10 per share. $10.00 PER SHARE!!!!!!
Some biotech companies TODAY have OS of 5 BILLION and PPS of $45.00.
IT DOES NOT MATTER THE OS IF THE COMPANY IS VALUABLE. Bottom line? DO YOU THINK CMTH is VALUE-ABLE? CaverStem seems to be showing us that it is in real time. I certainly think CMTH is value-able and thus I hold for the returns that I sincerely expect in the not distant future.
All posts my opinions only. NOT INVESTMENT ADVICE. Do your own due diligence.
-- Narrow is the way and few are those who find it. --
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM